Sarah Kim

Sarah Kim Ph.D.

Research Assistant Professor

Department: Pharmaceutics
Business Phone: (407) 313-7044
Business Email:

About Sarah Kim

Sarah Kim, Ph.D., is a research assistant professor at the University of Florida’s Center for Pharmacometrics and Systems Pharmacology in Lake Nona (Orlando), FL. Her desire is to be at the crossroads of mathematics and pharmacology. She graduated summa cum laude with the President’s honor with a Bachelor’s degree in 2008, and completed her Master’s degree in 2010 both in applied mathematics from Hanyang University, South Korea. She earned her doctorate in biomathematics at Florida State University in 2015. She developed mathematical models describing cerebral cortical folding patterns, epidemiological patterns, and heat conduction in semiconductor devices. In addition, she has been trained to deliver complex mathematical concepts meaningfully through a variety of teaching experience, which people who have different backgrounds could understand.

She attended Hanyang University with the highest entrance examination score of the College of Science and Technology, and received full tuition scholarships during the entire undergraduate education. She received the graduate research fellowship from the LG corporation Yonam foundation while pursuing her Master’s degree. She received scholarships from the Southern Scholarship Foundation and the Pi Mu Epsilon honor during the doctoral program. She also received several conference travel grants from the National Research Foundation of Korea, the Society of Mathematical Biology, the Florida State University, and the University of Florida.

Research Profile

Dr. Kim’s current research focuses on:

Mathematical modeling and simulations informing experimental designs to examine combinations of anti-M. tuberculosis agents to identify optimal regimens,

Developing a disease progression model-based clinical trial simulation tool designed to optimize clinical trial enrichment and design of studies to investigate efficacy of potential therapies for Duchenne Muscular Dystrophy,

Population pharmacokinetic/pharmacodynamic modeling and simulations to evaluate the impact of potential bio-in-equivalence on pharmacodynamics, and

Systems pharmacology modeling to improve drug safety, for which she received the David Goldstein Trainee Award from ASCPT in 2017 and two Presidential Trainee Awards from ASCPT in 2017 & 2018.


March 2019ACTIVE
A Model-based Clinical Trial Simulation Tool to Optimize Clinical Trial Design of Studies to Investigate Efficacy of Potential Therapies for Duchenne Muscular Dystrophy
CRITICAL PATH INSTITUTE · Principal Investigator


Florida State University
Hanyang University
Hanyang University